GMED News and Press, Globus Medical Inc. Class A From 02/19/24

2024-02-19 17:35:09 ET Major earnings expected after the bell on Tuesday include: Realty Income Corporation ( O ) Teladoc Health ( TDOC ) Palo Alto Networks ( PANW ) Chesapeake Energy Corporation ( CHK ) SolarEdge Technologies ( SEDG ) Read ...

AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024. A copy of the ...

2024-02-12 04:21:15 ET Summary In recent years, Alphatec Holdings has outperformed expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company is capitalizing on M&A-related disruptions at key competitors, w...

(NewsDirect) Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solution...

2024-02-05 16:38:27 ET More on Globus Medical Globus Medical: Merger Overhang Lingering Globus Medical, Inc. (GMED) Q3 2023 Earnings Call Transcript Globus Medical expects Q4 sales of about $615.5M Read the full article on Seeking Alpha For further de...

AUDUBON, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the promotion of Keith Pfeil as chief operating officer (COO) and chief financial officer (CFO). Having served as the Company’s CFO since Au...

2024-01-21 12:00:01 ET More on Intuitive Surgical, J&J, etc. Medtronic: Hugo's Global Rollout Is Positive; GLP-1 Is Negative Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuit...

2024-01-19 06:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-14 12:54:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the technology sector – especially regarding artificial intelligence – may have captured the spotlight, investors ought to consider adding healthcare stocks to their por...

2024-01-11 12:30:01 ET Truist Financial analyst issues BUY recommendation for GMED on January 11, 2024 01:00PM ET. The previous analyst recommendation was Buy. GMED was trading at $57.105 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...